| Literature DB >> 34233884 |
Roy Taylor1, Ambady Ramachandran2,3, William S Yancy4, Nita G Forouhi5.
Abstract
Entities:
Mesh:
Substances:
Year: 2021 PMID: 34233884 PMCID: PMC8261662 DOI: 10.1136/bmj.n1449
Source DB: PubMed Journal: BMJ ISSN: 0959-8138
Fig 1Type 2 diabetes develops as long term intake of excess food energy leads to accumulation of liver fat, driven by a vicious cycle of hepatic insulin resistance and hyperinsulinaemia. The raised liver fat level causes increased hepatic export of very low density lipoprotein (VLDL) triglycerides. If the subcutaneous fat depot cannot accommodate this, ectopic fat will build up, including in the pancreas. In people with susceptible β cells, the acute insulin response to food becomes diminished and de novo lipogenesis from glucose is enhanced. β Cell function can be restored if liver fat is reduced through weight loss. Figure is modified from Al-Mrabeh et al with permission5
The controversy about low carbohydrate or low calorie approaches to remission of type 2 diabetes: Areas of agreement and disagreement
| Low or very low carbohydrate diets | Low or very low calorie diets† | |
|---|---|---|
| Good for cardiovascular health | Improves indices of cardio-vascular risk for up to 2 years | Improves QRISK score up to 2 years |
| Long term outcome data | Not available | Not available |
| Long term weight management | The major problem. Need for continuing support and rescue management of weight regain | The major issue. Need for continuing support and rescue management of weight regain |
| Acceptability | Single centre reports acceptability | RCT data to 2 years shows ongoing compliance in the majority. |
| Weight loss: | ||
| RCT evidence | Significant difference from controls at 6 months only (reduction in the low carb group of 2.6-11.1 kg at 6 months, 3.1-9.8 kg at 1 year, and 2.0-6.8 kg at 2 years | Significantly different from controls up to 2 years. |
| Observational studies | Selected paying participants achieved 10 kg weight loss at 2 years.‡ | Mean weight loss of 13.7 kg at 6 months2 |
| Improvement in glucose control: | ||
| RCT evidence | Meta-analyses of multiple trials show significant decrease in HbA1c of 0.3-1.5% at 6 months. Decreases of 0.3-1.0% at 1 year and 0-0.6% at 2 years were not significantly different from active controls | One multisite trial found clinically important decrease in HbA1c at 6, 12, and 24 months with 36% remission at 2 years |
| Observational studies | Private clinic participants undertaking a very low carb diet while continuing hypoglycaemic agents achieved 0.9% decrease in HbA1c
| Observational data with withdrawal of all hypoglycaemic agents achieved a 1.1% fall in short duration diabetes and 0.6% fall in long duration diabetes over 6 months. |
| Remission of type 2 diabetes | A primary care series reports 46% of completers on continued metformin were in remission at an average of 2 years | RCT evidence of remission in 46% by intention to treat off all diabetes drugs at 12 months and 36% at 24 months from Direct. |
Low: 50-130 g/day or between 10-26% total energy; Very low: 20-50 g/day or under 10% total energy
700-1000 kcal/day (or 35-50% of a 2000 kcal/day intake) for a defined period then weight maintaining diet
This study used <30 g/day of carbohydrate initially.
Oral hypoglycaemic agents not stopped on commencing the diet.
All oral hypoglycaemic agents were stopped on commencing the diet in all studies.